systemic tnf blockade does not modulate synovial expression of the pro-inflammatory mediator hmgb1 in rheumatoid arthritis patients – a prospective clinical study系统性tnf封锁不调节滑膜炎性介质表达hmgb1风湿性关节炎患者的前瞻性临床研究.pdfVIP

下载本文档

0
0
约5.9万字
约 8页
2017-09-12 发布于上海
举报
版权申诉

systemic tnf blockade does not modulate synovial expression of the pro-inflammatory mediator hmgb1 in rheumatoid arthritis patients – a prospective clinical study系统性tnf封锁不调节滑膜炎性介质表达hmgb1风湿性关节炎患者的前瞻性临床研究.pdf

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

systemic tnf blockade does not modulate synovial expression of the pro-inflammatory mediator hmgb1 in rheumatoid arthritis patients – a prospective clinical study系统性tnf封锁不调节滑膜炎性介质表达hmgb1风湿性关节炎患者的前瞻性临床研究

Available online /content/10/2/R33 Vol 10 No 2 Open Access Research article Systemic TNF blockade does not modulate synovial expression of the pro-inflammatory mediator HMGB1 in rheumatoid arthritis patients – a prospective clinical study 1,2 2 2 3 2 Erik Sundberg , Cecilia Grundtman , Erik af Klint , Johan Lindberg , Sofia Ernestam , Ann- 2 2 1 Kristin Ulfgren , Helena Erlandsson Harris and Ulf Andersson 1Department of Woman and Child Health, Pediatric Rheumatology Research Unit, Karolinska Institutet/Karolinska University Hospital, Stockholm, Sweden 2Department of Medicine, Rheumatology Unit, Karolinska Institutet/Karolinska University Hospital, Stockholm, Sweden 3Department of Biotechnology, AlbaNova University Center, Royal Institute of Technology, Stockholm, Sweden Corresponding author: Erik Sundberg, erik.sundberg@ki.se Received: 21 Nov 2007 Revisions requested: 23 Jan 2008 Revisions received: 26 Feb 2008 Accepted: 17 Mar 2008 Published: 17 Mar 2008 Arthritis Research Therapy 2008, 10:R33 (doi:10.1186/ar2387) This article is online at: /content/10/2/R33 © 2008 Sundberg et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Abstract Introduction High-mobility group box chromosomal protein 1 infliximab therapy. Signs of inflammation were still evident in th